← All organizations

Achillion Pharmaceuticals

For profitWebsite ↗

Also known as: Achillion Pharmaceuticals

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Dec 1, 2019

Acquired by Alexion → AstraZeneca on Oct 16, 2019

Timeline

1990s

Jun 1, 1998
Achillion Pharmaceuticals— Founded

2010s

Oct 16, 2019
Alexion— Acquired By

2020s

Oct 13, 2020
AstraZeneca— Now

Drugs by trial phase (19 distinct, 23 trials)

Phase 2 (14 own, 0 via acquisition)

Phase 1 (5 own, 0 via acquisition)

Indications

Studied for

Recent trials (28)

NCT04170023Lead sponsorPhase 2Dec 1, 2019
NCT03459443Lead sponsorPhase 2Jun 20, 2018
NCT03369236Lead sponsorPhase 2Jun 12, 2018
NCT03555539Lead sponsorPhase 1May 15, 2018
NCT03472885Lead sponsorPhase 2May 8, 2018
NCT03384186Lead sponsorPhase 1Dec 1, 2017
NCT03124368Lead sponsorPhase 2Jul 1, 2017
NCT03181633Lead sponsorPhase 2Jun 1, 2017
NCT03108274Lead sponsorPhase 1Apr 18, 2017
NCT03053102Lead sponsorPhase 2Mar 31, 2017
NCT02512562CollaboratorPhase 1Jul 1, 2015
NCT01849562Lead sponsorPhase 2Apr 1, 2013
NCT01700179Lead sponsorPhase 1Sep 1, 2012
NCT01180790Study directorPhase 2Sep 1, 2010
NCT01180790Lead sponsorPhase 2Sep 1, 2010

Details

Founded: New Haven, CT, US Jun 1, 1998
Last known activity: Dec 1, 2019